Immunic, Inc. (IMUX) vs Nautilus Biotechnology, Inc. (NAUT)

Immunic, Inc. and Nautilus Biotechnology, Inc. are both Biotechnology companies. Immunic, Inc. and Nautilus Biotechnology, Inc. are of similar size ($127.2M and $126.1M). Across the 9 metrics below, Nautilus Biotechnology, Inc. leads on 5 and Immunic, Inc. on 4.

Valuation

Metric IMUX NAUT Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 3.12 0.94 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield (46.84%) (46.39%) (28.84%)
Free cash flow yield (22.15%) (42.05%) (23.03%)

Profitability

Metric IMUX NAUT Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (138.17%) (36.21%) (57.72%)
Return on assets (101.15%) (30.00%) (49.22%)
Return on invested capital 0.00% (83.32%) 0.00%

Growth

Metric IMUX NAUT Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 38.00% 16.07% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IMUX NAUT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.05 10.14 4.73
Net debt to EBITDA 0.15 1.67 0.96

Dividend

Metric IMUX NAUT Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric IMUX NAUT Biotechnology median
Market cap 127.17m 126.05m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack